XEOMIN (pronounced zee-oh-min) is the newest Neuromodulator in the U.S, becoming available in 2011 and is made by Merz Aesthetics. This new product acts like its predecessors Botox and Dysport in reducing or preventing contractions of the glabellar muscle between the eyes and other wrinkles caused by facial expression.
The difference in Xeomin (incobotulinumtoxinA) is that it does not carry the proteins that are typical of the other products. The potential advantage lies in the lessened likelihood of antibodies being formed to the proteins which – for a very limited number of patients – can render the product ineffective. (This typically is only seen in patients who have used botulinum toxin for an extended period of time.) The muscle-restricting action is, for all practical purposes, like Botox and Dysport and the dosing is the same as Botox Cosmetic. Which to choose will be patient preference.